The first authorised weight loss tablet has become available through selected UK pharmacies, marking a significant development in the treatment of obesity. Approved by the medicines regulator, the oral version of Wegovy offers an alternative to injectable weight loss medications and is expected to be introduced through supervised weight management programmes. Eligible patients will begin on lower doses before gradually increasing treatment under professional guidance. Pharmacists anticipate strong public demand, with many already reporting a surge in enquiries since the medicine’s approval. Health professionals hope the treatment will help reduce obesity-related illness and ease pressure on NHS services over time. However, pharmacy leaders have also warned about the growing risk of counterfeit medicines being sold online, urging people to obtain prescriptions only through legitimate healthcare providers. Experts stress that the medication is intended to complement healthy eating, physical activity, and long-term lifestyle changes rather than replace them.